Personal Information
Entreprise/Lieu de travail
Washing, D.C. Metro Area United States
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.biotechresources.net
À propos
The biotechnology economy remains strong with both local and global drivers fueling fantastic long-term growth for innovator, biosimilar, and CMO companies.
Biotech Resources Group (BRG) has 2 service arms:
I. Staffing: Clinical, Regulatory, & Manufacturing staff to allow clients to keep pace with trials & drug demand.
II. GMP Consulting: Focusing exclusively on biologic-based projects, Biotech Resources Group’s consulting arm works with client companies globally to design, build, start-up, and operate licenseable cGMP manufacturing facilities. Clients work with us because our hands-on involvement at each interval of the Concept-to-Commercialization sequence (below) at c
Mots-clés
european union
gmp
start-up
anvisa
fda
biotechnology
staffing
biologics manufacturing
regulatory
clinical
patent
robert valdes
biosimilar
biotech resources
Tout plus
Présentations
(1)Personal Information
Entreprise/Lieu de travail
Washing, D.C. Metro Area United States
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.biotechresources.net
À propos
The biotechnology economy remains strong with both local and global drivers fueling fantastic long-term growth for innovator, biosimilar, and CMO companies.
Biotech Resources Group (BRG) has 2 service arms:
I. Staffing: Clinical, Regulatory, & Manufacturing staff to allow clients to keep pace with trials & drug demand.
II. GMP Consulting: Focusing exclusively on biologic-based projects, Biotech Resources Group’s consulting arm works with client companies globally to design, build, start-up, and operate licenseable cGMP manufacturing facilities. Clients work with us because our hands-on involvement at each interval of the Concept-to-Commercialization sequence (below) at c
Mots-clés
european union
gmp
start-up
anvisa
fda
biotechnology
staffing
biologics manufacturing
regulatory
clinical
patent
robert valdes
biosimilar
biotech resources
Tout plus